Human Immunoglobulin G2 (IgG2) Antibody

<strong> Human Immunoglobulin G2 (IgG2) Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2015677_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> IgG2, ig, immnuoglobuling2, immnuoglobuling 2, immnuoglobuling, immnuoglobuling II, igg, IGHG 2, IGHG2, DKFZp686I04196, G2m Marker, Ig gamma 2 Chain C Region, IGHG2, Immunoglobulin Heavy Constant Gamma 2._x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Vattepu R, Sneed SL, Anthony RM. Sialylation as an Important Regulator of Antibody Function Front Immunol. 2022 Apr 7;13:818736._x000D_ 2: Palmeira P, Quinello C, Silveira-Lessa AL, Zago CA, Carneiro-Sampaio M. IgG placental transfer in healthy and pathological pregnancies Clin Dev Immunol. 2012;2012:985646._x000D_ 3: Saito S, Namisaki H, Hiraishi K, Takahashi N, Iida S. Engineering a human IgG2 antibody stable at low pH Protein Sci. 2020 May;29(5):1186-1195._x000D_ 4: Liu H, May K. Disulfide bond structures of IgG molecules: structural variations, chemical modifications and possible impacts to stability and biological function MAbs. 2012 Jan-Feb;4(1):17-23._x000D_ 5: Beenhouwer DO, Yoo EM, Lai CW, Rocha MA, Morrison SL. Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection Infect Immun. 2007 Mar;75(3):1424-35._x000D_ 6: Markham A. Guselkumab: First Global Approval Drugs. 2017 Sep;77(13):1487-1492._x000D_ 7: von Gunten S, Schneider C, Imamovic L, Gorochov G. Antibody diversity in IVIG: Therapeutic opportunities for novel immunotherapeutic drugs Front Immunol. 2023 Mar 28;14:1166821._x000D_ 8: Gelfand EW. Introduction Int Immunopharmacol. 2006 Apr;6(4):515-6._x000D_ 9: Zhang Y, Fan C, Zhang L, Ma X. Glycosylation-dependent antitumor therapeutic monoclonal antibodies Prog Mol Biol Transl Sci. 2019;163:471-485._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/30909702">10: Litzman J. Treatment of antibody immunodeficiency Vnitr Lek. 2019 Winter;65(2):126-130.</a>_x000D_ _x000D_ <strong>Products Related to Human Immunoglobulin G2 (IgG2) Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>